Earnings Feed
Start Free
Home/Filings/4/0001181431-12-036822
4//SEC Filing

McNamara Timothy 4

Accession 0001181431-12-036822

CIK 0000930553other
View on SEC.govCompany Profile

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 5:02 PM ET

Size

32.1 KB

Accession

0001181431-12-036822

Insider Transaction Report

Form 4
Period: 2012-06-06
ISTA PHARMACEUTICALS INCISTA
McNamara Timothy
VP Clinical Research & Medical
Transactions
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06−15,750→ 0 total
    Exercise: $3.63Exp: 2020-02-02→ Common Stock (15,750 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06−21,666→ 0 total
    Exercise: $6.42Exp: 2016-11-17→ Common Stock (21,666 underlying)
  • Disposition to Issuer

    Common Stock

    2012-06-06$9.10/sh−90,754$825,861→ 0 total
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06−8,879→ 0 total
    Exercise: $6.82Exp: 2021-02-07→ Common Stock (8,879 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06−6,750→ 0 total
    Exercise: $1.04Exp: 2019-02-03→ Common Stock (6,750 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06−26,916→ 0 total
    Exercise: $4.46Exp: 2018-02-08→ Common Stock (26,916 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06−95,625→ 0 total
    Exercise: $3.75Exp: 2021-11-30→ Common Stock (95,625 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06−25,073→ 0 total
    Exercise: $6.82Exp: 2021-02-07→ Common Stock (25,073 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06−7,500→ 0 total
    Exercise: $3.63Exp: 2020-02-02→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06−16,498→ 0 total
    Exercise: $1.04Exp: 2019-02-03→ Common Stock (16,498 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06−17,405→ 0 total
    Exercise: $7.43Exp: 2017-02-02→ Common Stock (17,405 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06−1,644→ 0 total
    Exercise: $6.77Exp: 2016-02-16→ Common Stock (1,644 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2012-06-06−30,000→ 0 total
    Exercise: $11.00Exp: 2014-11-15→ Common Stock (30,000 underlying)
Footnotes (13)
  • [F1]Disposed of pursuant to agreement and plan of Merger Agreement by and among the Company, Bausch & Lomb Incorporated and Inga Acquisition Corporation, as amended (the "Merger Agreement") in exchange for $9.10 per share, without interest, less any applicable withholding tax, on the effective date of the merger.
  • [F10]The option which was fully vested on 12/02/10was cancelled in the Merger Agreement in exchange for a cash payment equal to $1.67 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F11]The option which was fully vested on 12/17/08 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.68 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F12]The option which was fully vested on 12/16/08 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.33 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F13]The option which was fully vested on 11/15/08 was cancelled in the Merger Agreement.
  • [F2]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.35 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F3]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.28 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F4]The option of which 1,225 shares were unvested and 7,654 shares were vested was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.28 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F5]The option which was fully vested on 12/02/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.47 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F6]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.47 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F7]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $8.06 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F8]The option which was fully vested on 2/03/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $8.06 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
  • [F9]The option which was fully vested on 12/08/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $4.64 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).

Documents

1 file

Issuer

ISTA PHARMACEUTICALS INC

CIK 0000930553

→
Entity typeother

Related Parties

1
  • filerCIK 0001381689

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:02 PM ET
Size
32.1 KB
View on SEC.gov